Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 10;13(2):226. doi: 10.3390/cancers13020226

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Kaplan–Meier survival plots showing time to progression as a function of SLAMF7 expression on NK cells in blood and BM. (A) Plots for the combined ND+ RR+ pSCT MM patients divided into tertiles based on their dMFI values for SLAMF7 expression on CD56^bright (left) and CD56^dim NK cells (right) in blood. Numbers of patients in each tertile that are ND, RR, or pSCT are indicated adjacent to each plotted line. (B,C) Plots for only ND MM patients divided into halves above and below the median of dMFI values for SLAMF7 expression on their CD56^bright (left) and CD56^dim NK cells (right) in peripheral blood (B) and BM (C). Line designations for high-, medium-, and low-expression tertiles and halves are indicated in the individual panels. p values are listed for a Cox proportional hazards (CPH) test performed on all data points and Mantel–Cox (M–C) statistical analysis of each patient group divided into tertiles or halves.